الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 49 |  |  |
| | | from | 49 | | |
Abstract
The seventh most common cancer in women is OC. It is among the most prevalent gynecologic cancers. Families with a history of ovarian or breast cancer are considered a significant risk factor for OC. Epithelial OC is primarily considered to be a postmenopausal disease. An accurate histopathological evaluation is essential for efficient classification and management of OC.
The epithelial ovarian tumor develops from the ovary’s serous lining, which communicates with the peritoneum. Peritoneal carcinomatosis is the only sign of cancer dissemination in cases with primary advanced or recurrent EOC. PCI describes the extent and distribution of metastases.
Prognostic factors for peritoneal carcinomatosis (PC) include tumor histopathology, surgical PCI, CT-PCI, and CCS. All gynecologic oncologists consider EOC with advanced intraperitoneal tumor development to be a surgical challenge. Aggressive surgery (cytoreduction or tumor debulking) is one of the most recent treatment choices for advanced OC.
MDCT procedure combined with a routine application of a standardized PCI can offer more accurate multiregional analysis, allowing surgeons to provide patients with optimal treatment options.
A close association between CT-PCI and surgical PCI can assist surgeons in estimating the tumor load before surgery, which may aid in selecting patients for peritonectomy. There are errors in estimating PCI scores because their evaluation is dependent on the radiologist’s and surgeon’s experience.